loading
Translational Development Acquisition Corp stock is traded at $10.14, with a volume of 1,011. It is down -0.10% in the last 24 hours and up +0.50% over the past month. Translational Development Acquisition Corp is a newly organized blank check company.
See More
Previous Close:
$10.15
Open:
$10.1481
24h Volume:
1,011
Relative Volume:
0.04
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.10%
1M Performance:
+0.50%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$10.14
$10.15
1-Week Range:
Value
$10.11
$10.17
52-Week Range:
Value
$10.00
$10.30

Translational Development Acquisition Corp Stock (TDACU) Company Profile

Name
Name
Translational Development Acquisition Corp
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
TDACU's Discussions on Twitter

Compare TDACU with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Shell Companies icon
TDACU
Translational Development Acquisition Corp
10.14 0 0 0 0 0.00
Shell Companies icon
LION
Lionsgate Studios Corp
7.56 2.18B 3.13B 50.80M 555.00M 0.1772
Shell Companies icon
AACT
Ares Acquisition Corporation Ii
11.16 697.50M 0 16.92M -1.35M 0.29
Shell Companies icon
ANSC
Agriculture Natural Solutions Acquisition Corp
10.62 457.99M 0 1.30M 0 0.0301
Shell Companies icon
AAM
Aa Mission Acquisition Corp
10.22 449.41M 0 0 0 0.00
Shell Companies icon
EQV
Eqv Ventures Acquisition Corp
10.05 447.95M 0 0 0 0.00

Translational Development Acquisition Corp Stock (TDACU) Latest News

pulisher
Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development - Yahoo Finance

Mar 03, 2025
pulisher
Feb 14, 2025

Stock market today: Wall Street finishes a winning week just shy of a record - 69News WFMZ-TV

Feb 14, 2025
pulisher
Feb 14, 2025

Translational Development Acquisition Corp. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced - Yahoo Finance

Feb 14, 2025
pulisher
Feb 14, 2025

Quaker Oats recalls 10,000 boxes of Pearl Milling Company pancake mix for milk allergy risk - 69News WFMZ-TV

Feb 14, 2025
pulisher
Feb 14, 2025

Major SPAC Update: TDACU Splits Units into Separate Shares & Warrants Trading - StockTitan

Feb 14, 2025
pulisher
Feb 13, 2025

Trident Acquisitions stock hits 52-week high of $10.08 - MSN

Feb 13, 2025
pulisher
Feb 11, 2025

Trident Acquisitions stock hits 52-week high of $10.08 By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Jan 27, 2025

ImmuPharma (LON:IMM) Stock Price Up 9.3% – Here’s Why - Defense World

Jan 27, 2025
pulisher
Jan 27, 2025

Rockhopper Exploration (LON:RKH) Shares Down 8% – Here’s What Happened - Defense World

Jan 27, 2025
pulisher
Jan 27, 2025

Health In Tech, Inc.’s (NASDAQ:HIT) Quiet Period To End on February 3rd - Defense World

Jan 27, 2025
pulisher
Jan 27, 2025

Translational Development Acquisition Corp.’s Quiet Period Set To Expire on February 3rd (NASDAQ:TDACU) - Defense World

Jan 27, 2025
pulisher
Jan 24, 2025

Research Analysts Issue Forecasts for BHC FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 21, 2025

TDACU stock touches 52-week low at $10 amid market challenges - Investing.com

Jan 21, 2025
pulisher
Jan 18, 2025

Special Purpose Acquisition Company (SPAC) News and Analysis - SPACInsider

Jan 18, 2025
pulisher
Jan 14, 2025

TDACU stock touches 52-week low at $10.01 amid market shifts - Investing.com Canada

Jan 14, 2025
pulisher
Jan 13, 2025

NextCure Initiates Phase 1 Study for B7-H4 ADC Therapy to Treat Multiple Cancers_ - Defense World

Jan 13, 2025
pulisher
Jan 06, 2025

ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Yearend 2024 SPAC Market Update & Outlook - Business Wire

Jan 06, 2025
pulisher
Jan 02, 2025

Trident Acquisitions stock hits 52-week high at $10.04 - Investing.com India

Jan 02, 2025
pulisher
Jan 02, 2025

Trident Acquisitions stock hits 52-week high at $10.04 By Investing.com - Investing.com UK

Jan 02, 2025
pulisher
Dec 24, 2024

Translational Development Acquisition Corp. Announces Closing of $172.5 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option - Finansavisen

Dec 24, 2024
pulisher
Dec 24, 2024

Translational Development (TDACU) Raises $172.5M in Successful Nasdaq IPO, Begins Trading - StockTitan

Dec 24, 2024
pulisher
Dec 23, 2024

Translational Development Acquisition Corp. Announces the Pricing of $150,000,000 Initial Public Offering - The Eastern Progress Online

Dec 23, 2024
pulisher
Dec 23, 2024

Translational Development Acquisition Corp Launches $150M IPO on Nasdaq, Units to Trade as TDACU - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

Translational Development Acquisition Corp. (TDACU) Prices $150M IPO - SPACInsider

Dec 23, 2024
pulisher
Dec 20, 2024

What’s next for the man charged with killing UnitedHealthcare’s CEO? - 69News WFMZ-TV

Dec 20, 2024
pulisher
Dec 20, 2024

Italy's privacy watchdog fines OpenAI for ChatGPT's violations in collecting users personal data - 69News WFMZ-TV

Dec 20, 2024
pulisher
Dec 19, 2024

For airports, background music no longer is an afterthought - 69News WFMZ-TV

Dec 19, 2024
pulisher
Dec 18, 2024

The Fed expects to cut rates more slowly in 2025. What that could mean for mortgages, debt and more - 69News WFMZ-TV

Dec 18, 2024
pulisher
Dec 18, 2024

Valink Therapeutics Appoints Biopharmaceutical Veteran Martin D. Williams as Chair of the Board of Directors and Names Scientific Advisory Board - Business Wire

Dec 18, 2024
pulisher
Dec 09, 2024

(PDF) Translational Science: A Road Map for the Science of Reading - ResearchGate

Dec 09, 2024
pulisher
Nov 13, 2024

Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel - GlobeNewswire

Nov 13, 2024
pulisher
Oct 28, 2024

Deal Watch: Dealmakers Brace for Impact of Presidential Election - Law.com

Oct 28, 2024
pulisher
Oct 25, 2024

IPO NewsUS IPO Weekly Recap: Sizable tech and biotech IPOs are joined by a flurry of small names - Renaissance Capital

Oct 25, 2024
pulisher
Oct 22, 2024

(PDF) Measuring Translation Competence Acquisition - ResearchGate

Oct 22, 2024
pulisher
Sep 05, 2024

NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines - Business Wire

Sep 05, 2024
pulisher
Jul 11, 2024

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential - Ipsen

Jul 11, 2024
pulisher
May 08, 2024

Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function - Science

May 08, 2024
pulisher
May 06, 2024

Congruence Therapeutics Appoints Experienced Drug Developer Michael D. Harvey, Ph.D. as Chief Development Officer - PR Newswire

May 06, 2024
pulisher
May 02, 2024

Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition - MedCity News

May 02, 2024
pulisher
Apr 30, 2024

Rounding up the pharma firms investing the most in 2023 - Drug Discovery & Development

Apr 30, 2024
pulisher
Apr 17, 2024

NanoString Technologies to Be Acquired by Bruker Corporation - Business Wire

Apr 17, 2024
pulisher
Apr 06, 2024

Initial Public Offering (IPO) News Live Feed - StockTitan

Apr 06, 2024
pulisher
Mar 02, 2024

Novo Nordisk Expands Boston Area Research and Early Development - Genetic Engineering & Biotechnology News

Mar 02, 2024
pulisher
Nov 21, 2023

Merck to Acquire Caraway Therapeutics, Inc. - Business Wire

Nov 21, 2023
pulisher
Nov 14, 2023

Organoids Evolve from Academic Marvel to Industrial Tool - Genetic Engineering & Biotechnology News

Nov 14, 2023
pulisher
Nov 09, 2023

Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases - PR Newswire

Nov 09, 2023
pulisher
Nov 03, 2023

Locks on Translation Initiation May Restrain Cancer - Genetic Engineering & Biotechnology News

Nov 03, 2023
pulisher
Oct 15, 2023

Offerings News Live Feed - StockTitan

Oct 15, 2023
pulisher
Oct 04, 2023

Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer - BioSpace

Oct 04, 2023
pulisher
Sep 28, 2023

NIH launches new initiative: Tackling Acquisition of Language in Kids (TALK) - NIDCD

Sep 28, 2023
pulisher
Sep 26, 2023

NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD - Business Wire

Sep 26, 2023

Translational Development Acquisition Corp Stock (TDACU) Financials Data

There is no financial data for Translational Development Acquisition Corp (TDACU). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
shell_companies GIG
$10.11
price down icon 0.00%
$10.20
price up icon 0.20%
$11.60
price down icon 0.26%
shell_companies ALF
$10.23
price up icon 0.10%
$10.57
price down icon 0.38%
shell_companies EQV
$10.05
price up icon 0.00%
Cap:     |  Volume (24h):